GSDMC4 Inhibitors
GSDMC4 inhibitors constitute a specific class of chemical compounds engineered to regulate the activity of the Gasdermin C4 (GSDMC4) protein. Gasdermins are a family of proteins that have gained substantial attention in recent years for their critical roles in diverse cellular processes, particularly in regulating cell death and inflammation. GSDMC4, a member of the Gasdermin family, is currently under investigation to elucidate its precise functions within the context of cellular biology. GSDMC4 inhibitors are designed with the primary objective of selectively interacting with the GSDMC4 protein, thereby potentially modulating its activity and influencing downstream cellular events.
Typically, GSDMC4 inhibitors consist of small molecules or chemical compounds tailored to bind specifically to GSDMC4, targeting either its active site or allosteric sites. This interaction has the potential to alter GSDMC4's behavior, potentially affecting its ability to form membrane pores, engage in cell death pathways, or participate in other cellular functions. Researchers are primarily dedicated to unraveling the biological roles and mechanisms of GSDMC4 and how these inhibitors, by interacting with the protein, may provide insights into various cellular processes. The development of GSDMC4 inhibitors remains an active and dynamic area of research within the fields of molecular pharmacology and biochemistry, contributing to a deeper understanding of cell biology and the functions associated with Gasdermin family proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate acts by inhibiting dihydrofolate reductase, leading to a reduction in DNA synthesis and can downregulate the expression of rapidly dividing cells, which may include cells expressing certain proteins. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Azacitidine, a nucleoside analog, incorporates into RNA and DNA, which can disrupt nucleic acid synthesis and affect the transcription of certain genes. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A binds to the cyclophilins and inhibits calcineurin, which subsequently can reduce the activity of NF-AT transcription factors and alter gene expression profiles. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can lead to altered protein degradation pathways, potentially affecting the stability and expression of various regulatory proteins. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit proteasome activity and alter various metalloenzymes, which may result in the modulation of multiple signaling pathways and gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that can cause hyperacetylation of histones, leading to changes in chromatin structure and influencing gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate acts as an HDAC inhibitor, potentially affecting transcription and reducing expression of certain genes. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG is an Hsp90 inhibitor which can destabilize client proteins and may affect the function of proteins that regulate gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is another DNA methyltransferase inhibitor that incorporates into DNA, potentially affecting methylation status and gene expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that can affect the reading of acetylated histones, potentially altering the expression of certain genes. | ||||||